Unit DX is central Bristols deep tech incubator, home to the citys most innovative science and engineering companies. We empower scientists as entrepreneurs, providing facilities, investment, and mentoring. Our member companies are using emerging technologies such as biotechnology and synthetic biology, artificial intelligence, photonics and electronics, drones and robotics, advanced materials, and quantum computing to create new markets and deliver solutions to big societal problems. Unit DX was established in 2017 by the founders of Ziylo, a start-up that was acquired in 2018 by Novo Nordisk to develop smart insulins. In the process of spinning out the company, we realised that there was nowhere in central Bristol for science start-ups to go. Our first facility is now full and home to 32 businesses, which have collectively raised over £28 million in the last two years.
Unit DX is central Bristols deep tech incubator, home to the citys most innovative science and engineering companies. We empower scientists as entrepreneurs, providing facilities, investment, and mentoring. Our member companies are using emerging technologies such as biotechnology and synthetic biology, artificial intelligence, photonics and electronics, drones and robotics, advanced materials, and quantum computing to create new markets and deliver solutions to big societal problems. Unit DX was established in 2017 by the founders of Ziylo, a start-up that was acquired in 2018 by Novo Nordisk to develop smart insulins. In the process of spinning out the company, we realised that there was nowhere in central Bristol for science start-ups to go. Our first facility is now full and home to 32 businesses, which have collectively raised over £28 million in the last two years.
Company Information
- Industry
- Biotechnology
- Company Type
- Privately Held
- Founded
- unknown
- Employee Range
- 11-50
- Revenue Range
- Not available
Location
- Address
- Unit DX, St Philips Central Bristol
- City
- Region
- Postal Code
- BS2 0XJ
- Country